Return to PCORI.org 
Phased Large Awards for Comparative Effectiveness Research PFA - Cycle 3 2021
- What if some projected research costs for my PLACER submission are not covered by PCORI or they exceed the PLACER funding cap?
- Is a feasibility phase required for PLACER awards?
- I have questions about the suitability of my research project for this PFA. May I speak with a PCORI staff person?
- Under one PLACER award, are multiple RCTs allowed, similar to the program project/center grants used by NIH to establish large, multi-project efforts including a diverse array of research studies?
- How many co-PIs are acceptable? Could there be three, including two co-PIs who are running the clinical trial plus one co-PI who represents the DCC?
- Can a Stakeholder serve as a Dual-PI for awards under the PLACER PFA?
- With regard to stakeholder engagement, what qualifies as "experienced" leadership in stakeholder engagement? Can you give examples of individuals whose experience made them well-suited vs not well-suited for this role?
- Could you provide more information as to the role of the DCC? Does this need to be an existing standalone center that already performs the required functions?
- Is the use of PCORnet required for this (PLACER) PFA?
- Where can I find the slides from the Town Hall for the PLACER PFA?
- What types of study designs are acceptable under the PLACER PFA?
- Will my application be viewed more favorably if it addresses one of the exemplar research topics?
- If I am interested in using PCORnet as part of my study, how do I get started?
- What is the permitted page length for a Letter of Intent?
- I am an early career researcher. Am I eligible to apply?
- Are patients from other countries allowed to participate in studies funded through this announcement?
- May investigators build upon a current or prior PCORI-funded study or its findings?
- Will there be an evaluation and decision after the 18-month feasibility phase? What will that evaluation comprise? What is the process? What are the criteria for determining feasibility? Will it work like it does in the NIH Collaboratory?
- Should my study align with PCORI’s new priority areas? What topics is PCORI prioritizing? Is [Topic ABC] of interest to PCORI for this mechanism?